Supply Chain

Our approach

Strategic sourcing and procurement at Bristol Myers Squibb sit at the center of our global enterprise, connecting all our business units through a world-class network of suppliers and value-creating partnerships. We source hundreds of direct and indirect goods and services around the world for our various teams, including R&D, packaging and a multitude of professional services. After the completion of our merger with Celgene in late 2019 and the challenges brought on by the COVID-19 pandemic, we evolved our operating model, adapting our structure to include capabilities related to risk management, supply chain resilience and supplier management.

The BMS Global Supply Chain organization is driven from its purpose to lead the development, launch, and supply life cycle management of an innovative portfolio of products to accelerate science and deliver hope to patients through life-changing medicines. Our promise to patients, their families, and to healthcare providers is to deliver medicines wherever and whenever they are needed through an unencumbered, uninterrupted supply, globally.

We aim to seamlessly execute our purpose across all nodes of our supply chain, driven by five distinct purpose-driven pillars, including:

Patient Centric Mindset—creating and empowering an agile supply chain network so patients receive the medications they need, when and where they need them.
Leaders in Science and Technology—leveraging data, digital applications, and cutting-edge systems for best performance across service, quality, capital and cost.
Seamlessly Interconnected—serving as an integrator that brings together the voices of clinical, development and commercial to optimize our supply and logistics network.
Operating Model Agility—creating nimble processes for a flexible supply chain to meet the needs of patients with both precision and large-scale medicines.
Culture of Excellence—growing our people by encouraging curiosity, providing best experiences, and fostering continuous improvement to support our talent.

We seek partnerships and providers who share our ideals and who are inspired by our purpose. Our partner and supplier networks are integral parts of achieving heightened geographic reach, focused technical capabilities and increased network flexibility. In fact, during the COVID-19 pandemic, having strong global partners who understand our company, products and patients made a difference in our ability to maintain product quality, stability, and security. During the pandemic, we effectively managed the highly dynamic and unpredictable nature impacting global border restrictions, potential shipping lane delays, and most importantly ensuring we reached active clinical trial study participants as well as patients beginning or on maintenance therapies. We are proud of our ability to creatively solve and implement with urgency during the pandemic and are pleased to report that we did not see disruption in our clinical or commercial supply chains as a result.

COVID-19 has shown industry that a successful global supply chain takes a collective effort. Knowledge sharing and local expertise is critical to understanding unique country and patient situations. We believe that information sharing, supply and sourcing agility, and the ability to cultivate strong and reliable partnerships will be keys to success going forward.

Human Rights

Bristol Myers Squibb has been at the forefront of advocating for human rights globally since the 1980s. Its efforts have included signing the United Nations Global Compact and aligning its work to targets of the United Nations Sustainable Development Goals. In 2019, BMS became the first biopharmaceutical company to actively engage with a leading advocacy group and our transportation partners in the battle to end human trafficking.

To drive awareness of this issue and the education needed to end this crisis, January was declared National Slavery and Human Trafficking Prevention Month by a Presidential Proclamation in 2010. On January 29, 2020, the Sustainability, Corporate Security and Global Supply Chain/Transportation departments at BMS collaborated to host an event at our New Brunswick, New Jersey office, highlighting our collaboration with Truckers Against Trafficking (TAT), which addresses the critical intersection between human trafficking and the transportation industry. While we do not own and operate our own transportation fleet, we actively engage our supply chain transportation partners through the BMS Standards of Business Conduct and Ethics for Third Parties.

Also in this section

Supply Chain Supplier Diversity

Previous Download Report Next